bremelanotide

CHEBI:CHEBI_177849

Chemical Information

Molecular Formula
C50H68N14O10
Molecular Mass
1025.182
Charge
0
SMILES
O=C1N[C@@H](CC=2C=3C(NC2)=CC=CC3)C(=O)N[C@@H](CCCCNC(=O)C[C@H](NC(=O)[C@@H](NC(=O)C)CCCC)C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H]1CCCN=C(N)N)CC4=CC=CC=C4)CC=5NC=NC5)C(O)=O
InChI
InChI=1S/C50H68N14O10/c1-3-4-16-35(58-29(2)65)43(67)64-41-25-42(66)54-20-11-10-18-37(49(73)74)60-46(70)39(23-31-26-56-34-17-9-8-15-33(31)34)62-44(68)36(19-12-21-55-50(51)52)59-45(69)38(22-30-13-6-5-7-14-30)61-47(71)40(63-48(41)72)24-32-27-53-28-57-32/h5-9,13-15,17,26-28,35-41,56H,3-4,10-12,16,18-25H2,1-2H3,(H,53,57)(H,54,66)(H,58,65)(H,59,69)(H,60,70)(H,61,71)(H,62,68)(H,63,72)(H,64,67)(H,73,74)(H4,51,52,55)/t35-,36-,37-,38+,39-,40-,41-/m0/s1
InChIKey
FFHBJDQSGDNCIV-MFVUMRCOSA-N

Alternative Names

  • (3S,6S,9R,12S,15S,23S)-15-[[(2S)-2-acetamidohexanoyl]amino]-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-12-(1H-imidazol-5-ylmethyl)-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-1,4,7,10,13,18-hexazacyclotricosane-23-carboxylic acid

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

DRON_00010000
2176312
oboInOwl#hasDbXref
KEGG:D06569
core#notation
CHEBI:177849

Additional References

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

has_treatment
http://purl.obolibrary.org/obo/DOID_1923
rdf-schema#domain
https://w3id.org/def/predibionto#has_side_effect10354
owl#annotatedSource
t137291
owl#someValuesFrom
t3445232
oboInOwl#hasOBONamespace
chebi_ontology
DRON_00010000
2176312
generic_name
Bremelanotide Acetate
oboInOwl#hasDbXref
KEGG:D06569
oboInOwl#id
CHEBI:177849
core#notation
CHEBI:177849
rxcui
2176321
product_type
BULK INGREDIENT
marketing_category
BULK INGREDIENT
listing_expiration_date
20241231
dosage_form
INJECTION
route
SUBCUTANEOUS
marketing_start_date
20191108
active_ingredient_strength
1.75 mg/.3mL
active_ingredient_name
BREMELANOTIDE ACETATE
product_ndc
71052-359
labeler_name
Palatin Technologies
spl_id
2165b1e3-79db-ca37-e063-6294a90abe0b
package_ndc
71052-359-05
package_description
5 g in 1 CONTAINER (71052-359-05)
package_marketing_start_date
08-NOV-19
brand_name
Vyleesi
brand_name_base
Vyleesi
application_number
NDA210557
manufacturer_name
Palatin Technologies
unii
PV2WI7495P
spl_set_id
8c9607a2-5b57-4a59-b159-cf196deebdd9
pharm_class
Melanocortin Receptor Agonists [MoA]
oboInOwl#inSubset
http://purl.obolibrary.org/obo/chebi#2_STAR
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class